World Wealth Journal
SEE OTHER BRANDS

Bringing you the latest news on finance and banking

World Wealth Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wealth Journal.

Press releases published on May 22, 2025

Is 2025 the Year America Breaks Free from the IRS? Former White House Insider Says the System That’s Trapped Millions Could Soon Collapse

Is 2025 the Year America Breaks Free from the IRS? Former White House Insider Says the System That’s Trapped Millions Could Soon Collapse

WASHINGTON, May 22, 2025 (GLOBE NEWSWIRE) -- A new economic plan quietly gaining momentum in Washington could make 2025 the last year millions of Americans owe the federal government a penny. That’s the claim from Jim Rickards, a former advisor to the CIA, …

إطلاق منصة جديدة مدعومة بالذكاء الاصطناعي لتعزيز توظيف الشباب الإماراتي

إطلاق منصة جديدة مدعومة بالذكاء الاصطناعي لتعزيز توظيف الشباب الإماراتي

إطلاق «مسار الغرير» لتعزيز فرص توظيف الشباب الإماراتي عبر الذكاء الاصطناعي، من خلال مسارات مخصّصة وتوصيات تدريبية وربط مباشر مع سوق العمل DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- 22 مايو 2025 – دبي، الإمارات العربية المتحدة: أطلقت …

New AI-Powered Platform Launched to Boost Emirati Youth Employment

New AI-Powered Platform Launched to Boost Emirati Youth Employment

AI platform Massar Al Ghurair launched to equip Emirati youth with personalized career pathways, future-ready skills, and job-matching tools through ethical AI. DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- The Abdulla Al Ghurair …

Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting

Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting

One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20% Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advanced Melanoma Previously Treated with Immune Checkpoint Inhibitor SAN CARLOS, …

FAST TRACK GROUP Announces Pricing of $15 Million Initial Public Offering

FAST TRACK GROUP Announces Pricing of $15 Million Initial Public Offering

SINGAPORE, May 22, 2025 (GLOBE NEWSWIRE) -- FAST TRACK GROUP (“Fast Track” or the “Company”), a leading entertainment-focused event management and celebrity agency company, announced the pricing of its initial public offering of 3,750,000 ordinary shares ( …

Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)

Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)

New York, New York, May 22, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered offering …

Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC

Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC

-  63% response rate observed among 43 evaluable patients -  79% overall survival rate at 12-months; 9 months median progression-free survival -  Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 22, …

RCF Opportunities Fund II L.P. Files Early Warning Report Regarding Common Shares of Defense Metals Corp.

RCF Opportunities Fund II L.P. Files Early Warning Report Regarding Common Shares of Defense Metals Corp.

DENVER, May 22, 2025 (GLOBE NEWSWIRE) -- RCF Opportunities Fund II L.P. (“RCF”) reports that it has filed an early warning report under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in respect …

Abcourt annonce ses résultats du troisième trimestre terminé le 31 mars 2025

Abcourt annonce ses résultats du troisième trimestre terminé le 31 mars 2025

ROUYN-NORANDA, Québec, 22 mai 2025 (GLOBE NEWSWIRE) -- Mines Abcourt Inc. (« Abcourt » ou la « Société ») (TSX Venture: ABI) (OTCQB : ABMBF) annonce ses résultats du troisième trimestre terminé le 31 mars 2025. Toutes les valeurs monétaires dans ce …

Abcourt Announces its Results for the Third Quarter Ended March 31, 2025

Abcourt Announces its Results for the Third Quarter Ended March 31, 2025

ROUYN-NORANDA, Quebec, May 22, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the third quarter ended March 31, 2025. All monetary values in this press release are …

Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer

Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer

Phase 2 (Actuate-1801 Part 3B) trial topline results meet primary endpoint of improved survival in previously untreated patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) Oral presentation at the American Society of Clinical Oncology (ASCO) …

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting

CTLA-4 inhibitor ADG126 can be dosed at 20 mg/kg Q6W in combination with pembrolizumab with <20% Grade 3 adverse events In combination with pembrolizumab, ADG126 showed a 29% confirmed overall response rate (ORR) in microsatellite stable colorectal cancer …

Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

NEEDHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Petrus Announces Results of Annual General Meeting of Shareholders

Petrus Announces Results of Annual General Meeting of Shareholders

CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. ("Petrus" or the "Company") (TSX: PRQ) is pleased to announce that its shareholders approved all resolutions at its annual general meeting of shareholders held yesterday (the "Meeting …

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

LOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, …

Acceleware Ltd. Reports First Quarter 2025 Financial and Operating Results

Acceleware Ltd. Reports First Quarter 2025 Financial and Operating Results

CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), an advanced electromagnetic (“EM”) heating company with highly scalable solutions for large industrial applications, today announced its …

CH4 Global Unleashes Seaweed's Power to Combat Livestock Methane Emissions at Scale

CH4 Global Unleashes Seaweed's Power to Combat Livestock Methane Emissions at Scale

HENDERSON, NV, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- CH4 Global is pioneering the use of Asparagopsis seaweed to dramatically reduce methane emissions from cattle, offering a powerful, nature-based solution to one of agriculture's most …

VCI Global Revises Equity Agreement with 102% Premium Pricing, Enhancing Strategic Flexibility

VCI Global Revises Equity Agreement with 102% Premium Pricing, Enhancing Strategic Flexibility

KUALA LUMPUR, Malaysia, May 22, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”), a diversified global holding company with a strategic focus on AI …

Northview Residential REIT Announces May Distribution

Northview Residential REIT Announces May Distribution

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- Northview Residential REIT (the “REIT”) today announced its May 2025 cash distribution amounts on its outstanding …

Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting

Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting

BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the publication of an …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions